Financhill
Sell
36

CTTH Quote, Financials, Valuation and Earnings

Last price:
$0.0500
Seasonality move :
48.68%
Day range:
$0.0431 - $0.0461
52-week range:
$0.0170 - $0.1518
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
32.12x
Volume:
127.8K
Avg. volume:
41.3K
1-year change:
-23.17%
Market cap:
$2.6M
Revenue:
--
EPS (TTM):
-$637.36

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTTH
CTT Pharmaceutical Holdings, Inc.
-- -- -- -- --
BLMH
Blum Holdings, Inc.
-- -- -- -- --
HEWA
HealthWarehouse.com, Inc.
-- -- -- -- --
LBRG
LadyBug Resource Group, Inc.
-- -- -- -- --
SNYR
Synergy CHC
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTTH
CTT Pharmaceutical Holdings, Inc.
$0.0461 -- $2.6M -- $0.00 0% --
BLMH
Blum Holdings, Inc.
$0.62 -- $15.6M 1.01x $0.00 0% 0.57x
HEWA
HealthWarehouse.com, Inc.
$0.12 -- $6.8M 52.17x $0.00 0% 0.18x
LBRG
LadyBug Resource Group, Inc.
$0.0100 -- $2.3M -- $0.00 0% 0.33x
SNYR
Synergy CHC
-- -- -- -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTTH
CTT Pharmaceutical Holdings, Inc.
17.49% 3.053 0.89% 1.62x
BLMH
Blum Holdings, Inc.
-318.42% 0.068 97.97% 0.02x
HEWA
HealthWarehouse.com, Inc.
1206.82% 2.018 -- 0.39x
LBRG
LadyBug Resource Group, Inc.
-- 0.454 -- --
SNYR
Synergy CHC
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTTH
CTT Pharmaceutical Holdings, Inc.
-$1.6K -$7.3K -416.43% -668.98% -- -$16.4K
BLMH
Blum Holdings, Inc.
$2M -$1.5M -- -- -30.87% -$683K
HEWA
HealthWarehouse.com, Inc.
$3.6M -- -- -- -- -$4.9M
LBRG
LadyBug Resource Group, Inc.
-- -- -- -- -- --
SNYR
Synergy CHC
-- -- -- -- -- --

CTT Pharmaceutical Holdings, Inc. vs. Competitors

  • Which has Higher Returns CTTH or BLMH?

    Blum Holdings, Inc. has a net margin of -- compared to CTT Pharmaceutical Holdings, Inc.'s net margin of -63.85%. CTT Pharmaceutical Holdings, Inc.'s return on equity of -668.98% beat Blum Holdings, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- $99.5K
    BLMH
    Blum Holdings, Inc.
    40.93% -$0.25 -$2.8M
  • What do Analysts Say About CTTH or BLMH?

    CTT Pharmaceutical Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Blum Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings, Inc. has higher upside potential than Blum Holdings, Inc., analysts believe CTT Pharmaceutical Holdings, Inc. is more attractive than Blum Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    0 0 0
    BLMH
    Blum Holdings, Inc.
    0 0 0
  • Is CTTH or BLMH More Risky?

    CTT Pharmaceutical Holdings, Inc. has a beta of 0.371, which suggesting that the stock is 62.851% less volatile than S&P 500. In comparison Blum Holdings, Inc. has a beta of 1.903, suggesting its more volatile than the S&P 500 by 90.32%.

  • Which is a Better Dividend Stock CTTH or BLMH?

    CTT Pharmaceutical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Blum Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings, Inc. pays -- of its earnings as a dividend. Blum Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or BLMH?

    CTT Pharmaceutical Holdings, Inc. quarterly revenues are --, which are smaller than Blum Holdings, Inc. quarterly revenues of $4.8M. CTT Pharmaceutical Holdings, Inc.'s net income of -$7.3K is higher than Blum Holdings, Inc.'s net income of -$3.1M. Notably, CTT Pharmaceutical Holdings, Inc.'s price-to-earnings ratio is -- while Blum Holdings, Inc.'s PE ratio is 1.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings, Inc. is -- versus 0.57x for Blum Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- -- -$7.3K
    BLMH
    Blum Holdings, Inc.
    0.57x 1.01x $4.8M -$3.1M
  • Which has Higher Returns CTTH or HEWA?

    HealthWarehouse.com, Inc. has a net margin of -- compared to CTT Pharmaceutical Holdings, Inc.'s net margin of -0.86%. CTT Pharmaceutical Holdings, Inc.'s return on equity of -668.98% beat HealthWarehouse.com, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- $99.5K
    HEWA
    HealthWarehouse.com, Inc.
    42.86% -$0.00 $312.4K
  • What do Analysts Say About CTTH or HEWA?

    CTT Pharmaceutical Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand HealthWarehouse.com, Inc. has an analysts' consensus of -- which suggests that it could grow by 441.67%. Given that HealthWarehouse.com, Inc. has higher upside potential than CTT Pharmaceutical Holdings, Inc., analysts believe HealthWarehouse.com, Inc. is more attractive than CTT Pharmaceutical Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    0 0 0
    HEWA
    HealthWarehouse.com, Inc.
    0 0 0
  • Is CTTH or HEWA More Risky?

    CTT Pharmaceutical Holdings, Inc. has a beta of 0.371, which suggesting that the stock is 62.851% less volatile than S&P 500. In comparison HealthWarehouse.com, Inc. has a beta of 0.262, suggesting its less volatile than the S&P 500 by 73.772%.

  • Which is a Better Dividend Stock CTTH or HEWA?

    CTT Pharmaceutical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthWarehouse.com, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings, Inc. pays -- of its earnings as a dividend. HealthWarehouse.com, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or HEWA?

    CTT Pharmaceutical Holdings, Inc. quarterly revenues are --, which are smaller than HealthWarehouse.com, Inc. quarterly revenues of $8.4M. CTT Pharmaceutical Holdings, Inc.'s net income of -$7.3K is higher than HealthWarehouse.com, Inc.'s net income of -$72K. Notably, CTT Pharmaceutical Holdings, Inc.'s price-to-earnings ratio is -- while HealthWarehouse.com, Inc.'s PE ratio is 52.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings, Inc. is -- versus 0.18x for HealthWarehouse.com, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- -- -$7.3K
    HEWA
    HealthWarehouse.com, Inc.
    0.18x 52.17x $8.4M -$72K
  • Which has Higher Returns CTTH or LBRG?

    LadyBug Resource Group, Inc. has a net margin of -- compared to CTT Pharmaceutical Holdings, Inc.'s net margin of --. CTT Pharmaceutical Holdings, Inc.'s return on equity of -668.98% beat LadyBug Resource Group, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- $99.5K
    LBRG
    LadyBug Resource Group, Inc.
    -- -- --
  • What do Analysts Say About CTTH or LBRG?

    CTT Pharmaceutical Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand LadyBug Resource Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings, Inc. has higher upside potential than LadyBug Resource Group, Inc., analysts believe CTT Pharmaceutical Holdings, Inc. is more attractive than LadyBug Resource Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    0 0 0
    LBRG
    LadyBug Resource Group, Inc.
    0 0 0
  • Is CTTH or LBRG More Risky?

    CTT Pharmaceutical Holdings, Inc. has a beta of 0.371, which suggesting that the stock is 62.851% less volatile than S&P 500. In comparison LadyBug Resource Group, Inc. has a beta of -12.060, suggesting its less volatile than the S&P 500 by 1306.03%.

  • Which is a Better Dividend Stock CTTH or LBRG?

    CTT Pharmaceutical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LadyBug Resource Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings, Inc. pays -- of its earnings as a dividend. LadyBug Resource Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or LBRG?

    CTT Pharmaceutical Holdings, Inc. quarterly revenues are --, which are larger than LadyBug Resource Group, Inc. quarterly revenues of --. CTT Pharmaceutical Holdings, Inc.'s net income of -$7.3K is higher than LadyBug Resource Group, Inc.'s net income of --. Notably, CTT Pharmaceutical Holdings, Inc.'s price-to-earnings ratio is -- while LadyBug Resource Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings, Inc. is -- versus 0.33x for LadyBug Resource Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- -- -$7.3K
    LBRG
    LadyBug Resource Group, Inc.
    0.33x -- -- --
  • Which has Higher Returns CTTH or SNYR?

    Synergy CHC has a net margin of -- compared to CTT Pharmaceutical Holdings, Inc.'s net margin of --. CTT Pharmaceutical Holdings, Inc.'s return on equity of -668.98% beat Synergy CHC's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- $99.5K
    SNYR
    Synergy CHC
    -- -- --
  • What do Analysts Say About CTTH or SNYR?

    CTT Pharmaceutical Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Synergy CHC has an analysts' consensus of -- which suggests that it could fall by --. Given that CTT Pharmaceutical Holdings, Inc. has higher upside potential than Synergy CHC, analysts believe CTT Pharmaceutical Holdings, Inc. is more attractive than Synergy CHC.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    0 0 0
    SNYR
    Synergy CHC
    0 0 0
  • Is CTTH or SNYR More Risky?

    CTT Pharmaceutical Holdings, Inc. has a beta of 0.371, which suggesting that the stock is 62.851% less volatile than S&P 500. In comparison Synergy CHC has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CTTH or SNYR?

    CTT Pharmaceutical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Synergy CHC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CTT Pharmaceutical Holdings, Inc. pays -- of its earnings as a dividend. Synergy CHC pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTTH or SNYR?

    CTT Pharmaceutical Holdings, Inc. quarterly revenues are --, which are larger than Synergy CHC quarterly revenues of --. CTT Pharmaceutical Holdings, Inc.'s net income of -$7.3K is higher than Synergy CHC's net income of --. Notably, CTT Pharmaceutical Holdings, Inc.'s price-to-earnings ratio is -- while Synergy CHC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CTT Pharmaceutical Holdings, Inc. is -- versus -- for Synergy CHC. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTTH
    CTT Pharmaceutical Holdings, Inc.
    -- -- -- -$7.3K
    SNYR
    Synergy CHC
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock